As a model for the analysis of the fibrosuppressive role of estradiol, hepatic fibrosis was induced in male and female rats by the administration of a single dose of dimethylnitrosamine (DMN). The fibrotic response of the male liver after DMN treatment was significantly stronger than that of the female liver. In the male DMN model, estradiol reduced hepatic mRNA for type I and III procollagens and the tissue inhibitor of metalloproteinase-1 (TIMP-1), as well as deposition of type I and III collagen protein total hepatic collagen and malondialdehyde (MDA), a product of lipid peroxidation. Concomitant administration of a neutralizing antibody against rat estradiol enhanced fibrogenesis, as judged by the same parameters. Ovariectomy in the female model had a fibrogenic effect, inducing the hepatic expression of both types of procollagen and TIMP-1; in addition, the number of ␣-smooth muscle actin (␣-SMA)-positive cells in the liver increased; estradiol replacement was fibrosuppressive in the castrated-female model. In rat hepatic stellate cells incubated in primary culture with estradiol, cell number, type I collagen production, and ␣-SMA expression were all reduced. These findings suggest that estradiol suppressed the induction of hepatic fibrosis, and may in part underlie the more rapid progression in males of hepatic fibrosis and its complications. (HEPATOLOGY 1999;29:719-727.)Hepatic fibrosis is a consequence of severe liver damage and, in many chronic liver diseases, progresses to cirrhosis. 1,2 It consists of an abnormal accumulation of extracellular matrix proteins, particularly collagens. 3 Hepatocellular carcinoma is strongly associated with cirrhosis. 4 Among patients with cirrhosis and hepatocellular carcinoma, the male:female ratio is in the range of 2.3:1 to 2.6:1. 5,6 Both male and female livers contain high-affinity, low-capacity estrogen receptors 7,8 and respond to estrogens by regulating liver function. 9,10 This suggests that sex hormones may play a role in the progression from hepatic fibrosis to cirrhosis.It is now evident that hepatic stellate cells (HSC) (Ito cells, fat-storing cells, lipocytes) in the space of Disse undergo transformation under inflammatory stimuli into ␣-smooth muscle actin (␣-SMA)-positive myofibroblast-like cells, and are responsible for much of the collagen hypersecretion and nodule formation that occurs during hepatic fibrosis and cirrhosis. 11,12 Our preliminary studies suggested that fibrotic liver-collagen levels initially increase partly as a result of the balance between type I collagen and matrix metalloproteinase-1 (MMP-1) expression rates during the course of hepatic fibrosis in rats, as induced by a single dose of dimethylnitrosamine (DMN), 13 and that estradiol inhibits the myofibroblastic transformation of rat HSC in primary culture. 14 It is also noteworthy that oxygen-derived free radicals and lipid peroxidation have been implicated in hepatic fibrosis. 15-17 HSC may be activated by free radicals, induced by ascorbate/FeSO 4 , as well as by malondialdehyde ...